• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Chinook Therapeutics Inc (NQ: KDNY )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 10, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Chinook Therapeutics Inc

    < Previous 1 2 3 4 Next >
    The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
    Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
    Via Benzinga
    Wednesdays With Wedbush: Analyst Laura Chico On The State Of Biotech
    For most issues in the biotech sector, it was a rough 2021, especially when compared to the gains in the S&P 500 index, Wedbush's Laura Chi... 
    Via Benzinga
    Week In Review: BeiGene Raises $3.5 Billion In Shanghai STAR Board IPO
    Beijing's BeiGene announced its Shanghai STAR Exchange IPO will raise $3.5 billion in gross proceeds for the company, more than the predictions of $3 billion. It is the third listing for the company,... 
    Via Talk Markets
    Topics Initial Public Offering
    Exposures Securities Market
    76 Biggest Movers From Yesterday
    Gainers Expensify, Inc. (NASDAQ: EXFY) jumped 52.1% to settle at $41.06 on Wednesday after the company priced its IPO at $27 per share. RenovoRx, Inc. (NASDAQ: RNXT) shares... 
    Via Benzinga
    Topics Initial Public Offering
    Exposures Securities Market
    The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Gainers Chinook Therapeutics (NASDAQ:KDNY) shares increased by 28.75% to $15.76 during Friday's regular session. Trading volume for this security as of 12:30 EST is 1.... 
    Via Benzinga
    92 Biggest Movers From Friday
    Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the... 
    Via Benzinga
    64 Stocks Moving In Friday's Mid-Day Session
    Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the... 
    Via Benzinga
    The Past Week's Notable Insider Buys Include AppLovin, Cricut, Biotechs, And More
    With earnings-reporting season all but over, many insiders are free once more to buy or sell shares. Here are a few of the most noteworthy insider purchases that were reported in the past week. 
    Via Talk Markets
    The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
    Via Benzinga
    Exposures COVID-19
    The Past Week's Notable Insider Buys Included AppLovin, Cricut, Biotechs And More
    Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were making return trips to the buy window... 
    Via Benzinga
    The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
    Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
    Via Benzinga
    Aurinia Answers 'What's Next?' And Investors Punish AUPH Stock
    Aurinia snagged a pair of early-stage drugs for roughly $6.8 million on Tuesday, but AUPH stock tumbled into a key moving average. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Friday's Intraday Session
    Gainers Geron (NASDAQ:GERN) shares increased by 53.19% to $2.16 during Friday's regular session. As of 12:33 EST, Geron's stock is trading at a volume of 179.2... 
    Via Benzinga
    32 Stocks Moving In Friday's Mid-Day Session
    Gainers CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Sykes Enterprises,... 
    Via Benzinga
    Chinook Therapeutics' BION-1301 Shows Reduction In 24-Hour Proteinuria In Nephropathy Trial
    Chinook Therapeutics Inc (NASDAQ: KDNY) has announced interim data from the ongoing Phase 1/2 study of BION-1301 in patients with IgA Nephropathy (IgAN). The... 
    Via Benzinga
    The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7) Agios Pharmaceuticals, Inc... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Gainers BioCryst Pharmaceuticals (NASDAQ:BCRX) shares rose 11.13% to $11.32 during Friday's regular session. As of 08:06 EST, this security is trading at a volume of 8... 
    Via Benzinga
    The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
    Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,... 
    Via Benzinga
    Exposures Product Safety
    The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
    Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a preference for risky bets at the expense of... 
    Via Benzinga
    Exposures Product Safety
    The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ... 
    Via Benzinga
    Exposures COVID-19
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.